Latest: FDA Approves New Biosimilar for Oncology Treatment
Healthcare Business

TNX-102 SL Now Fourth FDA-Approved Treatment for Fibromyalgia

by American Journal Managed Care
0 Comments
0 Mins
This approval brings the total to 4 of medications approved to treat fibromyalgia; in addition to cyclobenzaprine HCl sublingual tablets (TNX-102 SL; Tonmya; Tonix Pharmaceuticals), there are pregabalin (Lyrica; Viatris), duloxetine (Cymbalta; Eli Lilly), and milnacipran (Savella; AbbVie).
Tags:
American Journal Managed Care
Author

American Journal Managed Care

Previous Post
Five Chemicals to Ditch in Your Home and Body Care Products and Why it Matters
Next Post
Dr. Michael Piepkorn on How the Discovery of the p16 Gene Transformed Familial Melanoma Diagnosis
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago